Public procurement notice: Contract Notice
Published: 2025-07-21
Buyer: Public Health Institution Specialized Hospital for prevention, treatment and rehabilitation of cardiovascular diseases – Ohrid
Country: MK
Region: MK003
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33111710
Estimated value: 479674 EUR
Submission deadline: 2025-08-15
Award criteria: price

Technical requirements: In order to qualify as competent for performing the subject agreement for public procurement, the economic operator shall submit the following documents as part of the technical offer:
- A decision for putting a medical device into circulation or a temporary or permanent permission for parallel import in accordance with the Law on Medicines and Medical Devices.
- A statement that on the day of the delivery, the offered medical devices and materials’ period of sterility is at least half from the estimated period of sterility. 
- A statement that the last generation of each medical device and material is offered in accordance with the technical specification requirements.
Catalogues for each part of the subject of procurement shall be submitted along with the offer. These catalogues shall contain a detailed description of the characteristics of the offered goods in either Macedonian or English, and those characteristics shall be clearly marked in accordance with the requirements in the technical specifications (a scanned catalogue attached on ESPP).
The subject of the agreement consists of 9 separate parts
The contracting authority shall ask from the seller whose offer is chosen as the most favourable to provide a bank guarantee for quality and promptly fulfillment of the agreement in the amount of 10% of the agreement value with VAT. The sellers are obliged to also submit a Statement for providing a guarantee for quality and promptly fulfillment of the agreement.
As a criterion for selecting the most favourable offer, the contracting authority shall use the most favourable economic offer based on: the best ratio between price and quality 
The most favourable offer shall be that offer that will be assessed as being the most favourable economic offer, i.e. the offer that will have the greatest number of total points as a combination of the points for each sub-element from the best ratio between price and quality. 
The elements of the best ratio between price and quality are the following: 
- price ...........................................60 points,
- quality........................................ 40 points.
The element quality is determined by a number of multicentric randomized studies related to the offered stent, published in a magazine that during the year in which it was published, has been reviewed in the Current Content referential database with a single impact factor (IF) of 5 or bigger than 5, with positive results sufficient for performing clinically relevant conclusions and their application in the broad clinical practice.
The publication results have to be about the offered stent or for the previous generation of that stent. In case the publication results are about the previous generation of the stent, the bidder is obliged to submit a statement verified by the manufacturer that the offered stent is an improved version of the same stent.
If the studies are about a different material of the stent, if a different medicine is used with the stent, if a different kind of a polymer is used on the stent, or if there are any kinds of changes to the stent design and platform, the studies shall not be accepted.
	For evaluating the element quality, every single multicentric randomized study shall receive 8 points. If the total number of points calculated for the studies is more than 40, the total number of points for the element quality shall be 40, as the maximum number of points.   
For proving the requirements for the element quality, the economic operators shall also submit: 
	- printed materials from the magazine in which the randomized studies are published or to provide the internet link through which the authenticity of the submitted document can be checked.
A coronary stent made of a chromium alloy (cobalt or platinum) with a continuous sinusoidal configuration and a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR


Winner: Publications Office of the European Union